Prognostic significance of serum potassium level for major adverse cardiac events and death in patients with coronary atherosclerotic disease
Abstract
Introduction: Serum potassium levels have been shown in some animal studies to be associated with the
process of atherosclerosis. We decided to assess the correlation of serum potassium level in ischemic heart disease
patients with disease severity and its relationship with prognosis in terms of major acute cardiac events (MACE).
Material and methods: This was a cross-sectional cohort study carried out at cardiology department of Rehman
Medical Institute, from July 2016 to 31st Aug. 2018 a period of 26 months. 622 patients were included in the
study. Clinical and angiographic characteristics were assessed based on the serum potassium level. Correlation of
serum potassium level with Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery
(SYNTAX) and Gensini scores was also evaluated. Follow up for MACE was carried out after one year.
Results: Mean serum potassium level was 3.93 ± 0.95 (mEq/l) in coronary artery disease patients. Serum
potassium level showed negative correlation with SYNTAX score (r = –0.60, p < 0.05) and Gensini score
(r = –0.64, p < 0.05). There was also a significant difference between low and high potassium level in relation
to the multi-vessel disease on coronary angiography (p < 0.05). Low potassium level was a good predictor of
adverse outcomes as shown by Kaplan-Meier analysis. Multivariate Cox regression analysis showed that serum
potassium level and diabetes were independent predictors of MACE (p < 0.05).
Conclusion: Low serum potassium level is correlated with more severe coronary atherosclerosis. Low potassium
levels are associated with significantly poor outcomes.
Keywords: coronary artery diseasecoronary angiographyprognosispotassium
References
- American Heart Association. Heart disease and stroke statistics: 2005 Update. Dallas, Tex: American Heart Association. 2004.
- Sica DA, Struthers AD, Cushman WC, et al. Importance of potassium in cardiovascular disease. J Clin Hypertens (Greenwich). 2002; 4(3): 198–206.
- Smith PD, Brett SE, Luykenaar KD, et al. KIR channels function as electrical amplifiers in rat vascular smooth muscle. J Physiol. 2008; 586(4): 1147–1160.
- Jin CZi, Kim HS, Seo EY, et al. Exercise training increases inwardly rectifying K(+) current and augments K(+)-mediated vasodilatation in deep femoral artery of rats. Cardiovasc Res. 2011; 91(1): 142–150.
- Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006; 290(3): R546–R552.
- Seo EY, Kim HJ, Zhao ZH, et al. Low K⁺ current in arterial myocytes with impaired K⁺-vasodilation and its recovery by exercise in hypertensive rats. Pflugers Arch. 2014; 466(11): 2101–2111.
- Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective mechanisms. Am J Physiol. 1995; 268(4 Pt 2): R825–R837.
- Ando K, Matsui H, Fujita M, et al. Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: possible role of its antioxidant action. Curr Vasc Pharmacol. 2010; 8(1): 59–63.
- Tobian L, Jahner TM, Johnson MA. High K diets markedly reduce atherosclerotic cholesterol ester deposition in aortas of rats with hypercholesterolemia and hypertension. Am J Hypertens. 1990; 3(2): 133–135.
- Zhang Y, Zhu CG, Guo YL, et al. Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population. PLoS One. 2014; 9(11): e113460.
- Cavusoglu E, Chopra V, Gupta A. Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease. Am J Hypertens. 2009; 22: 754–762.
- Guang Xian Zhao, Xiang Lan Jin, Ji Long Kang, Chun Zi Jin. Serum potassium levels are associated with coronary artery lesion severity in coronary artery disease. Int J Clin Exp Med. 2016; 9(2): 3705–3710.
- Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012; 126(16): 2020–2035.
- Catapano AL, Graham I, De Backer G, et al. ESC Scientific Document Group. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016; 37(39): 2999–3058.
- Williams B, Mancia G, Spiering W, et al. Authors/Task Force Members:, ESC Scientific Document Group . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
- https://www.health.govt.nz/our-work/preventative health wellness/tobacco control/tobacco-control information-practitioners/definitions smoking-status.
- https://www.medscape.com/answers/80279-119321/what is the seldinger technique for femoral central venous access and how is it performed.
- Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol. 2011; 57(24): 2389–2397.
- Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983; 51(3): 606.
- Ahn MJ, Kim MC, Ahn Y, et al. Impact of Complete Revascularization on Six-Year Clinical Outcomes and Incidence of Acute Decompensated Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. Am J Cardiol. 2018; 121(5): 544–551.
- Franse LV, Pahor M, Di Bari M, et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension. 2000; 35(5): 1025–1030.
- Tobian L. Protecting arteries against hypertensive injury. Clin Exp Hypertens A. 1992; 14(1-2): 35–43.
- Li X, Li Y, Jin J, et al. Increased serum cathepsin K in patients with coronary artery disease. Yonsei Med J. 2014; 55(4): 912–919.
- Wysowski DK, Kornegay C, Nourjah P, et al. Sex and age differences in serum potassium in the United States. Clin Chem. 2003; 49(1): 190–192.
- Goyal A, Spertus JA, Gosch K, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012; 307(2): 157–164.
- Sekiyama H, Nagoshi T, Komukai K. et.al. Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: paradoxical contribution of plasma glucose level and glycohemo¬globin. Cardiovasc Diabetol. 2013; 12: 4.
- Zhang H, Zhou CY. and Fu HY. The level of potassium in early patients with acute myocardial infarction and the analysis of its relevant factors. Chinese Journal of Prevention and Control of Chronic Diseases. 2011; 3: 026.
- Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005; 1(2): 219–227.
- Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5(1): 50–56.
- Kato S, Saito N, Kirigaya H, et al. Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease. Heart Vessels. 2016; 31(6): 871–880.